During the double-blind withdrawal period, 41.9% of ecopipam-treated patients relapsed compared with 68.1% of placebo-treated patients. Topline data were announced from a phase 3 trial evaluating ...
A study, published in Molecular Psychiatry, led by Prof. Bernard Lerer from the Department of Psychiatry at the Hadassah—Hebrew University Medical Center shows promising results for using psilocybin, ...
Add Yahoo as a preferred source to see more of our stories on Google. TikTok creator Baylen Dupree is the star of TLC’s latest docuseries, Baylen Out Loud. The series follows the West Virginia native ...
Topline data from Phase 3 study in patients with Tourette syndrome shows statistical significance between ecopipam and placebo for both the primary efficacy endpoint in pediatric subjects (p = 0.0084) ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (WGHP) — It’s a disorder that can have a big ...
PHILADELPHIA — The investigational agent ecopipam reduces tic severity in children and adolescents with Tourette syndrome (TS) without exacerbating common psychiatric comorbidities, results of a new ...
Researchers may have found a new way to target the sources of certain brain disorders. In a study led by scientists at Mass General Brigham, deep brain stimulation (DBS) was able to pinpoint ...
A community cinema in St Helens is raising awareness on the effects of Tourette syndrome through a new film screening.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results